Action of natural killer cells and macrophages in cancer
- 31 October 1993
- journal article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 5 (5), 714-718
- https://doi.org/10.1016/0952-7915(93)90126-d
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Natural killer cells and the MHC class I pathway of peptide presentationSeminars in Immunology, 1993
- Therapy of cancer metastasis by systemic activation of macrophages: From the bench to the clinicResearch in Immunology, 1993
- Allorecognition by NK cells: nonself or no self?Immunology Today, 1992
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1992
- Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells.The Journal of Experimental Medicine, 1992
- Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans.The Journal of Experimental Medicine, 1992
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytesCancer Immunology, Immunotherapy, 1991
- Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.The Journal of Experimental Medicine, 1980